Strategic Planning Group LLC Has $9.02 Million Stake in HCA Healthcare, Inc. $HCA

Strategic Planning Group LLC boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 47.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,165 shares of the company’s stock after acquiring an additional 6,848 shares during the period. HCA Healthcare makes up approximately 1.2% of Strategic Planning Group LLC’s holdings, making the stock its 26th largest holding. Strategic Planning Group LLC’s holdings in HCA Healthcare were worth $9,021,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ameriflex Group Inc. bought a new stake in HCA Healthcare in the 2nd quarter valued at $27,000. Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $27,000. Clearstead Trust LLC grew its position in HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares during the period. Harbor Capital Advisors Inc. lifted its holdings in shares of HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after acquiring an additional 34 shares during the period. Finally, Twin Peaks Wealth Advisors LLC bought a new position in HCA Healthcare during the 2nd quarter valued at about $40,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Down 2.8%

NYSE:HCA opened at $470.23 on Thursday. The stock’s fifty day simple moving average is $479.37 and its 200-day simple moving average is $426.03. The firm has a market capitalization of $107.30 billion, a P/E ratio of 18.18, a P/E/G ratio of 1.33 and a beta of 1.36. HCA Healthcare, Inc. has a 12-month low of $295.00 and a 12-month high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the business earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, December 29th. Stockholders of record on Monday, December 15th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a report on Monday, December 15th. Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. TD Cowen upped their target price on shares of HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Oppenheimer upped their price objective on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. Finally, Raymond James Financial set a $525.00 price target on HCA Healthcare in a report on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $485.95.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.